Hospital
Holy Cross Health, INC.
Holy Cross Health, INC. was paid $3.68M by Medicaid between Jan 2018 and Nov 2024, across 50 billing codes. Its largest line is 41899, Unlisted procedure, dentoalveolar structures — 83% of everything it billed.
33Billing provider infoHOLY CROSS HEALTH, INC.
GERMANTOWN, MD 20876
GERMANTOWN, MD 20876
33aNPI1245655638assigned 02/21/2014
33bProvider typeGeneral Acute Care Hospital
28Total paid$3.68M
24GClaims46,030
24DCodes billed50
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in Maryland
Rank by total paid#14 of 69
Median peer was paid$870K
This provider vs. median4.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 8,898 | $1.70M | |
| 2019 | 8,760 | $1.52M | |
| 2020 | 3,990 | $78K | |
| 2021 | 6,290 | $107K | |
| 2022 | 7,464 | $80K | |
| 2023 | 5,767 | $100K | |
| 2024incomplete | 4,861 | $91K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 41899 | Unlisted procedure, dentoalveolar structures | 83% | 711 | 687 | $3.05M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 6.6% | 3,077 | 2,806 | $242K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 3.2% | 1,875 | 1,707 | $118K |
| G0378 | Hospital observation service, per hour | 2.5% | 551 | 444 | $90K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 1.7% | 673 | 623 | $64K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.3% | 941 | 811 | $46K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,849 | 1,626 | $9K |
| J2704 | Injection, propofol, 10 mg | <1% | 702 | 658 | $9K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 714 | 676 | $6K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 927 | 825 | $5K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 541 | 514 | $5K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,011 | 2,275 | $3K |
38 more codes
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 1,183 | $3K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 5,349 | $3K |
| 36415 | Collection of venous blood by venipuncture | <1% | 5,674 | $2K |
| 84484 | <1% | 2,991 | $2K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 3,595 | $2K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 345 | $2K |
| 81001 | <1% | 2,610 | $2K | |
| 71045 | Radiologic examination, chest; single view | <1% | 2,214 | $1K |
| 80053 | Comprehensive metabolic panel | <1% | 2,687 | $846.24 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 370 | $822.94 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,053 | $626.16 |
| 71046 | Radiologic examination, chest; 2 views | <1% | 104 | $607.48 |
| 87400 | <1% | 41 | $585.22 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 85 | $329.43 |
| 0223U | <1% | 15 | $196.49 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 33 | $191.71 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 16 | $179.99 |
| 85610 | <1% | 320 | $173.26 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 976 | $154.77 |
| 83690 | <1% | 162 | $113.76 | |
| 85730 | <1% | 119 | $82.18 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 15 | $81.22 |
| 80076 | <1% | 88 | $78.06 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 14 | $61.56 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 15 | $40.52 |
| 85027 | <1% | 46 | $30.12 | |
| 87040 | <1% | 23 | $5.30 | |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 13 | $0.00 |
| 82077 | 0% | 50 | $0.00 | |
| 82550 | 0% | 15 | $0.00 | |
| 83735 | 0% | 71 | $0.00 | |
| 86850 | 0% | 14 | $0.00 | |
| 82553 | 0% | 15 | $0.00 | |
| 86901 | 0% | 14 | $0.00 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 0% | 52 | $0.00 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 0% | 30 | $0.00 |
| 81003 | 0% | 27 | $0.00 | |
| 86900 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKEESE, JULIE (VP & CFO)
| Provider | Location | Paid |
|---|---|---|
| Holy Cross Health, INC | Silver Spring, MD | $5.84M |
| Professional Services of Holy Cross | Silver Spring, MD | $3.30M |
| Holy Cross Health, INC. | Silver Spring, MD | $1.32M |
| Holy Cross Hospital Adult Day Care | Silver Spring, MD | $602K |
| Holy Cross Health, INC. | Mitchellville, MD | $123K |
| Trinity Health Mid-Atlantic Medical Group | Darby, PA | $35K |
| Professional Services of Holy Cross: Behavioral Health | Silver Spring, MD | $24K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.